|
Volumn 4, Issue 7, 2016, Pages e35-
|
Substantial benefits from finding the most effective BCG strain
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BCG VACCINE;
BACTERIAL GENOME;
BACTERIAL STRAIN;
DRUG EFFICACY;
GENETIC DIFFERENCE;
GENETIC HETEROGENEITY;
GENOTYPE;
HUMAN;
INFECTION PREVENTION;
INFECTION RISK;
LETTER;
MYCOBACTERIUM BOVIS BCG;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
STRAIN DIFFERENCE;
TUBERCULOSIS;
CHILD;
CLASSIFICATION;
DEVELOPING COUNTRY;
FEMALE;
GENETICS;
INFANT;
LUNG TUBERCULOSIS;
MALE;
MYCOBACTERIUM BOVIS;
NEWBORN;
ORGANIZATION AND MANAGEMENT;
POVERTY;
PRESCHOOL CHILD;
PREVENTIVE MEDICINE;
PUBLIC HEALTH;
SOCIOECONOMICS;
BCG VACCINE;
CHILD;
CHILD, PRESCHOOL;
DEVELOPING COUNTRIES;
FEMALE;
HUMANS;
INFANT;
INFANT, NEWBORN;
MALE;
MYCOBACTERIUM BOVIS;
POVERTY;
PREVENTIVE MEDICINE;
PUBLIC HEALTH;
SOCIOECONOMIC FACTORS;
TUBERCULOSIS, PULMONARY;
|
EID: 84990060432
PISSN: 22132600
EISSN: 22132619
Source Type: Journal
DOI: 10.1016/S2213-2600(16)30108-4 Document Type: Letter |
Times cited : (7)
|
References (5)
|